Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 7, 2012
The 4G/4G genotype of the PAI-1 (serpine-1) 4G/5G polymorphism is associated with decreased lung allograft utilizationA Sapru, J G Zaroff, L Pawlikowska, et al.
Bone Marrow Transplantation|September 7, 2010
A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescentsJ Styczynski, B Tallamy, I Waxman, et al.
Bone Marrow Transplantation|May 7, 2014
Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell diseaseM Bhatia, Z Jin, C Baker, et al.
Human Immunology|May 20, 2008
Strategies and technical challenges in allele level Class II typing in 2578 bone marrow transplantation donor-recipient pairsT M Williams, T Winden, M Setterholm, et al.
Tissue Antigens|January 1, 1996
Large-scale DRB and DQB1 oligonucleotide typing for the NMDP registry: progress report from year 2J Ng, C K Hurley, C Carter, et al.
Human Gene Therapy|September 25, 2003
High-level expression of cancer/testis antigen NY-ESO-1 and human granulocyte-macrophage colony-stimulating factor in dendritic cells with a bicistronic retroviral vectorR B Batchu, A M Moreno, S Szmania, et al.
Blood|July 27, 2001
Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramersS Szmania, A Galloway, M Bruorton, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2001
In vitro generation of Epstein-Barr virus-specific cytotoxic T cells in patients receiving haplo-identical allogeneic stem cell transplantationP Musk, S Szmania, A T Galloway, et al.
Bone Marrow Transplantation|July 31, 2007
Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseasesM B Bradley, P Satwani, L Baldinger, et al.
Bone Marrow Transplantation|March 21, 2000
The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor-recipient pairsC K Hurley, L A Baxter-Lowe, A B Begovich, et al.
Pageof 6